Literature DB >> 1863425

Huperzine A--a potent acetylcholinesterase inhibitor of use in the treatment of Alzheimer's disease.

S J Geib1, W Tückmantel, A P Kozikowski.   

Abstract

Huperzine A, 9-amino-13-ethylidene-11-methyl-4-azatricyclo [7.3.1.0(3,8)]trideca-3(8),6,11-trien-5-one, C15H18N2O, Mr = 242.32, monoclinic, P2(1)/n, a = 8.8574 (6), b = 12.1833 (7), c = 12.4278 (7) A, beta = 99.956 (5) degrees, V = 1320.9 (1) A3, Z = 4, Dx = 1.22 g cm-3, lambda(Cu K alpha) = 1.54178 A, mu = 5.75 cm-1, F(000) = 520, T = 296 K, RF = 6.30% for 1402 reflections with Fo greater than or equal to 5 sigma(Fo) and 183 parameters. The pyridone ring is planar and the stereochemistry of the C(11)--C(12) double bond is E.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863425     DOI: 10.1107/s0108270190008952

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  2 in total

1.  The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques.

Authors:  Ludise Malkova; Alan P Kozikowski; Karen Gale
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

Review 2.  Utility of nutraceutical products marketed for cognitive and memory enhancement.

Authors:  Graham J McDougall; Vonnette Austin-Wells; Teena Zimmerman
Journal:  J Holist Nurs       Date:  2005-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.